From: SARS-CoV2 RT-PCR assays: In vitro comparison of 4 WHO approved protocols on clinical specimens and its implications for real laboratory practice through variant emergence
BERLIN
HKU
DAAN Gene®
IPP
0.861
95% CI [0.800–0.923]
0.830
95% CI [0.763–0.898]
0.542
95% CI [0.447–0.637]
0.5419
0.5169
95% CI [0.422–0.611]
95% CI [0.799–0.923]